🇺🇸 FDA
Patent

US 10208103

Use of HDL-related molecules to treat and prevent proinflammatory conditions

granted A61KA61K38/00A61K38/16

Quick answer

US patent 10208103 (Use of HDL-related molecules to treat and prevent proinflammatory conditions) held by The Regents of the University of California expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/16, A61K38/1709, A61P